Adhering to the service tenet of "Integrity, Innovation, Harmony, and Win-win", We have established a complete one-stop procurement and comprehensive solution service system.
4-Methylpregabalin cas 313651-25-1 is a drug developed by Pfizer and related to pregabalin, which similarly acts as an analgesic with effectiveness against difficult to treat "atypical" pain syndromes such as neuropathic pain.
4-methyl pregabalin cas 313651-25-1
Product introduction：
Cas: 313651-25-1
MF: C9H19NO2
Molecular Weight: 173.25
Purity: 99.0%
Perform standard: USP
Description: 4-Methylpregabalin cas 313651-25-1 is a drug developed by Pfizer and related to pregabalin, which similarly acts as an analgesic with effectiveness against difficult to treat "atypical" pain syndromes such as neuropathic pain. The effectiveness of 4-Methylpregabalin cas 313651-25-1 and its older relative gabapentin against pain syndromes of this kind (which tend to respond poorly to other analgesic drugs) has led to their widespread use, and these drugs have subsequently been found to be useful for many other medical applications, including as anticonvulsants, muscle relaxants, anxiolytics and mood stabilisers.
Application: 4-Methylpregabalin cas 313651-25-1 is similar to Pregabalin, which is a noveγ-aminobutyric acid (GABA) receptor agonist, can block the voltage-dependent calcium channels to reduce neurotransmitter release. 4-Methylpregabalin cas 313651-25-1 is also used for postherpetic neuralgia (pain that occurs after shingles) and pain caused by nerve damage from diabetes or a spinal cord injury.
Other chemical names: (3R,4R)-3-(Aminomethyl)-4,5-dimethylhexanoic acid, Hexanoic acid, 3-(aminomethyl)-4,5-dimethyl-, (3R,4R)-, Pregabalin Impurity 75,
(3R,4R)-3-(Aminomethyl)-4,5-dimethylhexanoic acid
Sign up for our latest news & articles. We won’t give you spam mails.
Note: We do not publish your email
